Cryoport (NASDAQ:CYRX) stock identified change of 66.45% away from 52-week low price and recently located move of -17.51% off 52-week high price. It has market worth of $812.80M. CYRX stock has been recorded 21.66% away from 50 day moving average and 18.83% away from 200 day moving average. Moving closer, we can see that shares have been trading 13.60% off 20-day moving average.
On May 07, 2020, Cryoport (NASDAQ:CYRX) a global leader in life sciences solutions, declared financial results for the three-month period ended March 31, 2020.
We reported revenue of $9.8 million for the First Quarter of 2020, an increase of 47% from the First Quarter of 2019, said Jerrell Shelton, Chief Executive Officer of Cryoport. This was driven largely by record revenue from our commercial agreements supporting Gilead’s YESCARTA® and Novartis’ KYMRIAH® which contributed $2.9 million to the First Quarter of 2020, representing an increase of 110% compared with the First Quarter of 2019. In the first quarter, we experienced minimal disruption of our commercial portfolio resulting from the COVID-19 pandemic and are working closely with our partners to ensure eligible patients continue to have access to these life-saving therapies.
In April, Gilead’s Kite Pharma renewed its agreement with Cryoport, which cover its entire portfolio of therapies in development as well as YESCARTA®. The ongoing rollouts of both YESCARTA® and KYMRIAH® to patients in the Americas, EMEA and APAC are expected to drive a continued ramp in activity related to our agreements supporting these commercial products. Revenue from our agreement with bluebird bio to support its commercial launch of ZYNTEGLO™ is expected to commence in the second half of 2020.
Our revenue growth in the First Quarter was also attributable to Cryogene, our Houston based Bioservices operation, which contributed revenue of $1.3 million. Cryogene specializes in the long-term secure storage of biological specimens, materials and samples for research purposes and is expected to continue to operate with some, but relatively minimal, impact from the COVID-19 pandemic. The Industrials sector company, Cryoport noticed change of 1.47% to $20.64 along volume of 592941 shares in recent session compared to an average volume of 408.87K shares. The stock observed return of 9.55% in 5 days trading activity. The stock was at 26.01% over one month performance. CYRX’s shares are at 9.67% for the quarter and driving a 31.38% return over the course of the past year and is now at 25.39% since this point in 2018.
The average volatility for the week at 5.83% and for month was at 6.07%. There are 39.38M shares outstanding and 37.18M shares are floated in market. Right now the stock beta is 0.74.